﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/moderna-to-become-marketing-authorization-holder-in-japan-for-spikevax-12379</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/thyrocare-unveils-new-brand-identity-12390</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/natco-launches-first-generic-version-of-nexavar-tablets-in-the-us-12389</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/jubilant-hollisterstier-enters-into-agreement-of-1496-mn-with-us-govt-to-expand-critical-vaccine-manufacturing-capacity-12388</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/us-fda-accepts-new-drug-application-filed-by-avillion-for-astrazenecas-pt027-12387</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/mezzion-pharma-receives-clear-fda-path-forward-for-the-approval-of-udenafil-for-single-ventricle-heart-disease-12386</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/tetra-bio-pharma-appoints-cfo-12385</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-approves-roches-evrysdi-for-use-in-babies-under-two-months-with-sma-12384</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/usfda-accepts-dupilumab-for-priority-review-in-adults-with-prurigo-nodularis-12383</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/ayu-health-hospitals-announces-t-expansion-plan-in-rajasthan-12382</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/payback-india-announces-a-strategic-partnership-with-apollo-pharmacy-12381</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/entod-pharmaceuticals-gets-dcgi-nod-to-carry-out-the-phase-3-trials-of-005-atropine-eye-drops-12380</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/novavax-initiates-phase-3-trial-of-its-covid-19-omicron-booster-12391</loc><lastmod>2022-06-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>